Researchers of CBM developed a new and atypical biosensor based on whole-cell eukaryotic Saccharomyces cerevisiae able to detect bioavailable copper in situ in a linear range from 10-3 to 10-8 M
A lire aussi
A new anticancer therapeutic strategy targeting the protein kinases LIMKs via new innovative chemical compounds
29 October 2024
par Isabelle Frapart
2024, November 15 - Seminar of Gyula TIRCSO
25 October 2024
par Isabelle Frapart
2024, November 8 - Seminar of Sophia MISSOURRY
25 October 2024
par Isabelle Frapart